"antituberculosis" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "anti",
        "3": "tuberculosis"
      },
      "expansion": "anti- + tuberculosis",
      "name": "prefix"
    }
  ],
  "etymology_text": "anti- + tuberculosis",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "antituberculosis (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with anti-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical effects",
          "orig": "en:Pharmaceutical effects",
          "parents": [
            "Pharmacology",
            "Biochemistry",
            "Medicine",
            "Biology",
            "Chemistry",
            "Sciences",
            "All topics",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2007 March 20, Lawrence K. Altman, “Rise of a Deadly TB Reveals a Global System in Crisis”, in New York Times",
          "text": "XDR-TB is defined as tuberculosis that is resistant to the two most important antituberculosis drugs (isoniazid and rifampin)[…].",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Acting to combat or counteract tuberculosis"
      ],
      "id": "en-antituberculosis-en-adj-ylUwIA2u",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "tuberculosis",
          "tuberculosis"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) Acting to combat or counteract tuberculosis"
      ],
      "tags": [
        "not-comparable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "antituberculosis"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "anti",
        "3": "tuberculosis"
      },
      "expansion": "anti- + tuberculosis",
      "name": "prefix"
    }
  ],
  "etymology_text": "anti- + tuberculosis",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "antituberculosis (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with anti-",
        "English terms with quotations",
        "English uncomparable adjectives",
        "en:Pharmaceutical effects"
      ],
      "examples": [
        {
          "ref": "2007 March 20, Lawrence K. Altman, “Rise of a Deadly TB Reveals a Global System in Crisis”, in New York Times",
          "text": "XDR-TB is defined as tuberculosis that is resistant to the two most important antituberculosis drugs (isoniazid and rifampin)[…].",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Acting to combat or counteract tuberculosis"
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "tuberculosis",
          "tuberculosis"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) Acting to combat or counteract tuberculosis"
      ],
      "tags": [
        "not-comparable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "antituberculosis"
}